Obesity and metabolic syndrome

The Ministry of Health Obesity Clinical Practice Guidelines published in 2004 and 2016 endorses the role of surgery indicated to patients with body mass index (BMI) higher than 37.5 without any co-morbidities (Class III obesity), or above 32.5 (Class II obesity) with co-morbidities such as diabetes, hypertensions, hyperlipidaemia and obstructive sleep apnoea (OSA). Results from recent randomised trials suggested that metabolic surgery combined with intensive medical therapy is more effective than optimal medical treatment alone for glycaemic control in obese individuals with Type 2 diabetes. Additional benefits were noted in the control of blood pressure and lipid levels in the surgery group. The benefits of metabolic surgery among anti-diabetes interventions for “diabesity” is also recognised by recent joint statement from International Diabetes Organizations in Diabetes Surgery Summit (DSS-II). At the SKH SWITCH Centre, we have a multi-disciplinary specially trained team to ensure your safety along the journey before and after operation. Our surgeons are specially trained in advanced laparoscopic and metabolic surgery internationally.